TrialInternational journal of molecular sciences2019

A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia

Yael Lebenthal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.